Prediction Case File
YouTubePartially Resolved

2 Stocks I'm Buying In August 2026

2 extracted signals · 1 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
04 Aug 2026, 17:55 UTC
Recorded by Tahlil Plus
04 Aug 2026, 19:54 UTC
Video preview for 2 Stocks I'm Buying In August 2026
Source overview

AI-generated source summary

The analysis covers two stocks: GFL and QCOM. For GFL, the current price is $42.00, with a target of $50.00 and a fail bound of $34.22. The stock is considered to be in an uptrend. The analysis highlights GFL's strong financial performance, including acquisitions and pricing power, suggesting a potential for further growth. The forward P/E ratio is noted as being low, indicating undervaluation. For QCOM, the current price is $151.57, with a target of $165.00 and a fail bound of $140.00. The stock is considered to be in a downtrend, but the analysis suggests this is unjustified. The decline is attributed to a slowdown in the smartphone market and competition from Apple designing its own chips. However, the report emphasizes growth in other segments like automotive and IoT, with strong forward guidance for non-handset revenue growth. The company is expected to benefit from long-term contracts and a transition away from legacy business models.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Partially Resolved
Signals
2
Extracted from this source
Open
1
Still being tracked
Successful
1
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
100%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    2 eligible signals linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
311
Historical success
34.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail